Cancer cells may evade immune attack by releasing an antioxidant protein (PRDX1) that deprives T cells of the reactive oxygen species required for activation. Eliminating tumor-derived PRDX1 increased immune activity and restricted tumor growth, sensitizing resistant models to anti–PD-1 and anti–CTLA-4 checkpoint blockade.
Related products
| Catalog No. | Product Name | Description | Target |
|---|---|---|---|
| MS870039 | InVivo Plus Anti-Mouse PD-1 Antibody (RMP1-14) | InVivo Plus Anti-Mouse CD279/PDCD1/PD1 Antibody (RMP1-14) [RMP1-14] (MS870039) is a rat monoclonal antibody detecting Programmed cell death protein 1 in in vivo blocking of PD-1/PD-L signaling. Suitable for Mouse. | CD279, PD1, PDCD1, Programmed cell death protein 1, Protein PD-1, PD-1 |
Quick access
Contact Us
+86-27-65523339
Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China
中文
English
한국어
日本語
Español
Français
Русский